James Shin
Stock Analyst at Deutsche Bank
(0.75)
# 3,117
Out of 4,667 analysts
18
Total ratings
50%
Success rate
-34.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | Maintains: Buy | $1,025 → $1,015 | $751.10 | +35.14% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $290.41 | +5.02% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $70.10 | -14.41% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $58.42 | -22.97% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $39.61 | +51.48% | 1 | May 23, 2024 | |
| GILD Gilead Sciences | Initiates: Hold | $75 | $89.66 | -16.35% | 1 | Nov 9, 2023 | |
| ABBV AbbVie | Initiates: Hold | $150 | $172.08 | -12.83% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $748.52 | +6.88% | 1 | Nov 9, 2023 | |
| MRK Merck & Co. | Initiates: Buy | $115 | $99.32 | +15.79% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $2.80 | +257.14% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.62 | +358.89% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $2.66 | +2,531.58% | 1 | Dec 12, 2022 |
Eli Lilly
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $751.10
Upside: +35.14%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $290.41
Upside: +5.02%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $70.10
Upside: -14.41%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $58.42
Upside: -22.97%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $39.61
Upside: +51.48%
Gilead Sciences
Nov 9, 2023
Initiates: Hold
Price Target: $75
Current: $89.66
Upside: -16.35%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $172.08
Upside: -12.83%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $748.52
Upside: +6.88%
Merck & Co.
Nov 9, 2023
Initiates: Buy
Price Target: $115
Current: $99.32
Upside: +15.79%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.80
Upside: +257.14%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $2.62
Upside: +358.89%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $2.66
Upside: +2,531.58%